Biological drugs in auto immune diseases


Biologic therapies  rheumatologic diseases, which are targeted at molecules tangled in the mechanisms of  immune system, offer a substitute to the present treatment approaches of disease-modifying anti-rheumatic drugs and immunosuppressive medications. Biologics, or biological response modifiers, might be given to treat autoimmune diseases, including many types arthritis, such as rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Biologics work by unsettling the inflammation process that leads to joint pain and destruction. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, disease-modifying antirheumatic drugs (DMARDs) are conservatively used in dealing with autoimmune inflammatory diseases.



 


    Related Conference of Biological drugs in auto immune diseases

    December 12-13, 2024

    23rd World Congress on Nutrition and Food Chemistry

    Rome, Italy
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands
    January 27-28, 2025

    25th World Congress on Medicinal Chemistry and Drug Design

    Bangkok, Thailand
    March 13-14, 2025

    2nd International Conference on Drug Discovery and Development

    Prague, Czech Republic
    April 07-08, 2025

    15th World Congress on Chemistry

    Vancouver, Canada
    May 14-15, 2025

    17th International Conference on Clinical Chemistry

    Toronto, Canada
    June 25-26, 2025

    15th World Congress on Analytical & Bioanalytical Techniques

    Aix-en-Provence, France
    June 26-27, 2025

    14th World Congress on Chromatography

    Paris, France
    October 27-28, 2025

    15th International Chemistry Congress

    London, UK

    Biological drugs in auto immune diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in